US firm Amgen has invested in Oxford Nanopore, which has developed handheld gene sequencing technology that uses nanopores in combination with electronics to perform direct, real-time sequencing of DNA and RNA.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,